Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00903240 · ClinicalTrials.gov registry record

Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer

A clinical trial, sponsored by Predictive Biosciences.

Completed
Registry status
1,000
Enrollment target

NCT00903240: Completed study, sponsored by Predictive Biosciences.

NCT00903240 is a clinical trial that has completed, run by Predictive Biosciences. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00903240 has completed, sponsored by Predictive Biosciences.

COMPLETED
Registry status
1,000 participants
Enrollment target

Study Summary

The purpose of this study is to detect recurrent bladder cancer using a combination of protein and DNA biomarkers in urine

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2009-05
Est. Completion 2010-10
Predictive Biosciences

2 total trials

What the finished NCT00903240 record still lists

NCT00903240 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00903240 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00903240 about?

NCT00903240 is a clinical study titled "Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer". The purpose of this study is to detect recurrent bladder cancer using a combination of protein and DNA biomarkers in urine

What is the current status of trial NCT00903240?

This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2009-05. Estimated completion is 2010-10.

Who is sponsoring clinical trial NCT00903240?

This trial is sponsored by Predictive Biosciences, which has 2 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00903240, the US trial registry maintained by the National Library of Medicine. NCT00903240 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.